The minimum clinically important difference for EQ-5D index: a critical review

Silvia Coretti, Matteo Ruggeri, Paul McNamee

Research output: Contribution to journalReview article

55 Citations (Scopus)

Abstract

The European Quality of Life-5 Dimensions Questionnaire (EQ-5D) is the most common instrument to value health outcomes under the patient's perspective. Several studies have investigated whether observed changes are meaningful to patients, using a variety of approaches to estimate the minimum clinically important difference (MCID). This study provides an overview of the state of art of the estimation of the MCID for the three-level EQ-5D index based on the UK scoring algorithm, critically assessing the available evidence. The interest in estimation of MCID for the EQ-5D has been increasing in recent years. However, some additional standardization in the estimation procedures may be of value, in order to enhance the ability to make comparisons across measures and disease areas. Further methodological research might also contribute to reducing gaps between theory and practice.

Original languageEnglish
Pages (from-to)221-233
Number of pages13
JournalExpert Review of Pharmacoeconomics & Outcomes Research
Volume14
Issue number2
Early online date13 Mar 2014
DOIs
Publication statusPublished - Apr 2014

Fingerprint

Quality of Life
Health
Research
Surveys and Questionnaires

Keywords

  • EQ-5D
  • Euro QoL
  • minimum clinically important difference
  • minimum relevant difference
  • review
  • smallest worthwhile effect

Cite this

The minimum clinically important difference for EQ-5D index : a critical review. / Coretti, Silvia; Ruggeri, Matteo; McNamee, Paul.

In: Expert Review of Pharmacoeconomics & Outcomes Research, Vol. 14, No. 2, 04.2014, p. 221-233.

Research output: Contribution to journalReview article

@article{dc2d21925d3045639ba43187db12856b,
title = "The minimum clinically important difference for EQ-5D index: a critical review",
abstract = "The European Quality of Life-5 Dimensions Questionnaire (EQ-5D) is the most common instrument to value health outcomes under the patient's perspective. Several studies have investigated whether observed changes are meaningful to patients, using a variety of approaches to estimate the minimum clinically important difference (MCID). This study provides an overview of the state of art of the estimation of the MCID for the three-level EQ-5D index based on the UK scoring algorithm, critically assessing the available evidence. The interest in estimation of MCID for the EQ-5D has been increasing in recent years. However, some additional standardization in the estimation procedures may be of value, in order to enhance the ability to make comparisons across measures and disease areas. Further methodological research might also contribute to reducing gaps between theory and practice.",
keywords = "EQ-5D, Euro QoL, minimum clinically important difference, minimum relevant difference, review, smallest worthwhile effect",
author = "Silvia Coretti and Matteo Ruggeri and Paul McNamee",
year = "2014",
month = "4",
doi = "10.1586/14737167.2014.894462",
language = "English",
volume = "14",
pages = "221--233",
journal = "Expert Review of Pharmacoeconomics & Outcomes Research",
issn = "1473-7167",
publisher = "Expert Reviews Ltd.",
number = "2",

}

TY - JOUR

T1 - The minimum clinically important difference for EQ-5D index

T2 - a critical review

AU - Coretti, Silvia

AU - Ruggeri, Matteo

AU - McNamee, Paul

PY - 2014/4

Y1 - 2014/4

N2 - The European Quality of Life-5 Dimensions Questionnaire (EQ-5D) is the most common instrument to value health outcomes under the patient's perspective. Several studies have investigated whether observed changes are meaningful to patients, using a variety of approaches to estimate the minimum clinically important difference (MCID). This study provides an overview of the state of art of the estimation of the MCID for the three-level EQ-5D index based on the UK scoring algorithm, critically assessing the available evidence. The interest in estimation of MCID for the EQ-5D has been increasing in recent years. However, some additional standardization in the estimation procedures may be of value, in order to enhance the ability to make comparisons across measures and disease areas. Further methodological research might also contribute to reducing gaps between theory and practice.

AB - The European Quality of Life-5 Dimensions Questionnaire (EQ-5D) is the most common instrument to value health outcomes under the patient's perspective. Several studies have investigated whether observed changes are meaningful to patients, using a variety of approaches to estimate the minimum clinically important difference (MCID). This study provides an overview of the state of art of the estimation of the MCID for the three-level EQ-5D index based on the UK scoring algorithm, critically assessing the available evidence. The interest in estimation of MCID for the EQ-5D has been increasing in recent years. However, some additional standardization in the estimation procedures may be of value, in order to enhance the ability to make comparisons across measures and disease areas. Further methodological research might also contribute to reducing gaps between theory and practice.

KW - EQ-5D

KW - Euro QoL

KW - minimum clinically important difference

KW - minimum relevant difference

KW - review

KW - smallest worthwhile effect

U2 - 10.1586/14737167.2014.894462

DO - 10.1586/14737167.2014.894462

M3 - Review article

C2 - 24625040

VL - 14

SP - 221

EP - 233

JO - Expert Review of Pharmacoeconomics & Outcomes Research

JF - Expert Review of Pharmacoeconomics & Outcomes Research

SN - 1473-7167

IS - 2

ER -